| Literature DB >> 34199133 |
Elizabeth M Messersmith1, Dathan T Smerchek1, Stephanie L Hansen1.
Abstract
Growth-promoting technologies such asEntities:
Keywords: cattle; estradiol; growth; hormones; trace minerals; trenbolone acetate; zinc
Year: 2021 PMID: 34199133 PMCID: PMC8300159 DOI: 10.3390/ani11071914
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Figure 1Proposed physiological pathway interactions of combination E2 + TBA steroidal implants and Zn in skeletal muscle cells as discussed in this review. Specific focus is placed on the genomic and non-genomic steroid hormone pathways, protein and DNA synthesis pathway, and the corresponding points at which evidence suggests Zn interacts with these pathways. Definitions: AKT (Protein kinase B), Androgen GPR (Androgen specific G protein-coupled receptor), E2 (Estradiol), EGFR (Epidermal growth factor receptor), ERK (Extracellular signal-regulated kinase), GPER-1 (G protein-coupled estrogen receptor 1), hbEGF (Heparin binding epidermal growth factor-like growth factor), IGF-1 (Insulin-like growth factor 1), IGF1R (Insulin-like growth factor 1 receptor), IRS (Insulin receptor substrate), MMP2/9 (Matrix metalloproteinase 2/9), mTOR (Mammalian target of rapamycin), mTORC1 (Mammalian target of rapamycin 1), mTORC2 (Mammalian target of rapamycin 2), PDK1 (Phosphoinositide-dependent kinase-1), PI3K (Phosphoinositide 3-kinases), RAS (Ras family of related GTPase proteins), SR (Sarcoplasmic reticulum), TBA (Trenbolone acetate), ZIP7 (Zinc transporter SLC39a7), ZIP8 (Zinc transporter SLC39a8), ZIP14 (Zinc transport SLC39a14).
Review of literature examining steroidal implants and zinc metabolism in cattle.
| Ref. | Sex | Steroidal Implant 1 | Potency 2 | Supplemental Zn 3 | Day 4 | ∆ 5 ADG, % | ∆ 5 Plasma Zn, % | ∆ 5 Liver Zn, % |
|---|---|---|---|---|---|---|---|---|
| [ | Steer | 200 mg TBA + 20 mg E2 | High | 0 | 69 | -- | -- | +10.6 |
| 30 a | 69 | -- | -- | +11.0 | ||||
| 100 a | 69 | -- | -- | +22.9 | ||||
| [ | Steer | 200 mg TBA + 20 mg E2 | High | 30 a | 13/14 | +29.0 | −11.2 | −6.6 |
| [ | Steer | 200 mg P + 20 mg EB | Moderate | 0 | 59 | +7.6 | +1.8 | −26.1 |
| 200 a | 59 | +17.4 | +3.2 | +30.7 | ||||
| 200 b | 59 | -- | −15.0 | +8.5 | ||||
| [ | Heifer | 200 mg TP + 20 mg EB | Moderate | 0 | 50 | +11.0 | +7.0 | −38.2 |
| 200 a | 50 | +17.0 | −2.5 | +25.4 | ||||
| 200 b | 50 | −26.0 | +24.7 | −40.8 | ||||
| [ | Steer | 80 mg TBA +16 mg E2 (Initial) | Moderate | 100 c | 14/15 | -- | −3.1 | −1.0 |
| 200 mg TBA + 20 mg E2 | High | 100 c | 14/15 | -- | −12.8 | +4.8 | ||
| [ | Steer | 200 mg TBA + 20 mg E2 | High | 0 | 18 | +8.0 | −4.6 | -- |
| 30 a | 18 | +3.1 | −9.7 | -- | ||||
| 100 a | 18 | +4.5 | −7.0 | -- | ||||
| 150 a | 18 | +21.6 | −3.5 | -- | ||||
| [ | Steer | 200 mg TBA | High | 55 c | 2 | -- | −4.3 | −16.2 |
| 120 mg TBA +24 mg E2 | Moderate | 55 c | 2 | -- | −8.5 | −16.2 | ||
| [ | Steer | 200 mg P + 20 mg EB (Initial) | Moderate | 360 d mg·steer−1·d−1 | 28 | -- | −4.8 | +12.2 |
| 80 mg TBA +16 mg E2 | Moderate | 360 d mg·steer−1·d−1 | 56 | -- | −7.7 | +4.7 |
1 Steroidal implant hormone concentrations are listed using the following abbreviations: E2: estradiol, EB: estradiol benzoate, P: progesterone, TBA: trenbolone acetate, TP: testosterone propionate. All steroidal implants were given as the terminal implant, unless otherwise noted as initial implant. 2 Steroidal implant potency is arbitrarily categorized as low, moderate, or high based on hormone combination and dose. 3 Supplemental Zn is expressed as mg/kg DM, unless otherwise stated. Source of Zn supplemented is represented by superscript: a inorganic, b organic, c blend of inorganic and organic, d means of inorganic and organic Zn supplementation were combined due to no source differences. 4 Represents day relative to administration of the steroidal implant used in each study. 5 The percent delta (∆) represents the effect of steroidal implant compared to non-implanted cohorts on growth and Zn metabolism parameters on the noted day post-steroidal implant administration. Changes in plasma Zn concentrations for [118] represent changes in serum Zn concentrations.